Manuel Prieto

Manuel Prieto is an AI Scientist at AstraZeneca, where they focus on revolutionizing healthcare through technology by researching AI applications in protein structure prediction and optimizing drug selection processes. With over a decade of experience in AI and biomedical engineering, they have made significant contributions to personalized medicine by leveraging biomarkers and real-world data to enhance cancer immunotherapy. Previously, as a Machine Learning Engineer at Philips, Manuel developed AI-based medical imaging systems that improved early diagnosis of various conditions. Additionally, their early career included work as a Bioinformatics Scientist at Illumina, where they advanced personalized medicine through machine learning applications. Manuel continues their education at the Universitat de Barcelona.